The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.60
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.05 (8.333%)
Open: 0.625
High: 0.625
Low: 0.625
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Parsley Box to exit AIM as shares wilt since IPO

Fri, 18th Nov 2022 11:16

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Parlsey Box Group PLC, up 43% at 2.36 pence, 12-month range 1.2p-47.74p. The Edinburgh-based meal delivery firm proposes to re-register as a private limited company as it sets December 14 as date for a general meeting to vote on the plan. At the general meeting next month, the proposal needs 75% approval of votes cast by shareholders. Parsley Box says it has received irrevocable undertakings representing about 36% of the company's issued share capital to vote in favour of going private. The firm only started trading publicly on London's AIM in March 2021 with a placing price of 200 pence per share.

----------

MyHealthChecked PLC, up 15% at 1.84p, 12-month range 1.1p-3.8p. The Cardiff-based healthcare company proposes a capital reduction, to be voted on at a general meeting on December 6. It seeks shareholder approval to cancel its share premium account and capital redemption reserve, as well as to cancel deferred shares. This would "eliminate [its] retained losses and create distributable reserves equal to the balance", it says. Its current negative distributable reserves position means it is currently unable to declare dividends or buy back its shares. A resolution would grant it authority to purchase up to 78 million of its ordinary shares, which is around 10% of its share capital, which it would intend to cancel. A court hearing to confirm the capital reduction is expected on January 17 next year.

----------

AIM - LOSERS

----------

Eco Atlantic Oil & Gas Ltd, down 54% at 19.15p, 12-month range 17p-46p. The stock nears a 12-month low as the oil and gas explorer says that its Gazania-1 well had reached its target depth of 2,360 metres but did not show evidence of commercial hydrocarbons. The well, which was spudded on October 10, will now be plugged and abandoned. "While it is naturally disappointing not having made a commercial discovery, the Gazania-1 well was only the first of four wells we have planned for the next 18-24 months across our wider portfolio," says Gil Holzman, co-founder & chief executive officer of Eco Atlantic. The company will now move onto executing plans for more exploration wells.

----------

N4 Pharma PLC, down 27% at 2.05p, 12-month range 1.51p-8.69p. The Derby, England-based pharmaceutical company raises GBP1 million in placing of 50.0 million shares at an issue price of 2p. Also launches broker offer for an initial expected value of GBP250,000 at the same price. Says net proceeds will be used to progress its development work "relating to the loading of SiRNA onto Nuvec, including to commit to doing in-vivo studies and also to explore acquisition opportunities".

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 May 2021 19:22

TRADING UPDATES: Gamma tips 2021 revenue jump; Smart Metering progress

TRADING UPDATES: Gamma tips 2021 revenue jump; Smart Metering progress

Read more
17 Mar 2021 16:31

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 Feb 2021 12:34

N4 Pharma losses widen as it works on commercialising Nuvec

(Sharecast News) - Pre-revenue specialist pharmaceuticals company N4 Pharma reported an operating loss of £1.56m in its final results on Wednesday, widening from the £0.95m loss a year earlier.

Read more
24 Feb 2021 10:25

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

Read more
24 Feb 2021 10:03

N4 Pharma Loss Widens As Ramps Up R&D Investment At "Pivotal Time"

N4 Pharma Loss Widens As Ramps Up R&D Investment At "Pivotal Time"

Read more
11 Feb 2021 11:53

N4 Pharma Shares Jump On European Patent Approval For Nuvec

N4 Pharma Shares Jump On European Patent Approval For Nuvec

Read more
11 Feb 2021 11:21

AIM WINNERS & LOSERS: MediaZest Soars As Kicks Off 2021 With Deal Wins

AIM WINNERS & LOSERS: MediaZest Soars As Kicks Off 2021 With Deal Wins

Read more
9 Dec 2020 14:04

IN BRIEF: N4 Pharma Raises GBP2 Million To Fund Development Work

IN BRIEF: N4 Pharma Raises GBP2 Million To Fund Development Work

Read more
4 Dec 2020 10:33

UK WINNERS & LOSERS SUMMARY: Cineworld Falls On Warner Streaming Plans

UK WINNERS & LOSERS SUMMARY: Cineworld Falls On Warner Streaming Plans

Read more
3 Dec 2020 13:39

N4 Pharma shares surge on latest from Nanomerics collaboration

(Sharecast News) - Specialist pharmaceuticals company N4 Pharma updated the market on its ongoing research collaboration agreement with Nanomerics on Thursday.

Read more
3 Dec 2020 10:40

N4 Pharma Shares Soar As Cancer Drug Moves To Phase Two Of Programme

N4 Pharma Shares Soar As Cancer Drug Moves To Phase Two Of Programme

Read more
9 Nov 2020 14:22

N4 Pharma working with Nanomerics on oncology programme

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has appointed Nanomerics to investigate the potential utility of its 'Nuvec' delivery system in cancer therapy.

Read more
9 Nov 2020 14:20

N4 Pharma Plans Nuvec Oncology Treatment Study With UCL's Nanomerics

N4 Pharma Plans Nuvec Oncology Treatment Study With UCL's Nanomerics

Read more
5 Nov 2020 18:07

UK TRADING UPDATE SUMMARY: Zotefoams Hails Record Third Quarter Sales

UK TRADING UPDATE SUMMARY: Zotefoams Hails Record Third Quarter Sales

Read more
17 Sep 2020 14:36

IN BRIEF: N4 Pharma Pretax Loss Widens; Aims To Maximise Nuvec Uses

IN BRIEF: N4 Pharma Pretax Loss Widens; Aims To Maximise Nuvec Uses

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.